Aylin Akifova - Publications

Real-world utilization patterns and association of dd-cfDNA with biopsy and rejection.

Journal: Frontiers in medicine

Published: May 25, 2026

Daratumumab as rescue therapy in refractory recurrent FSGS after kidney transplantation: a case series.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: April 01, 2026

Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension.

Journal: The Lancet regional health. Europe

Published: March 30, 2026

Improving diagnostic performance of kidney allograft rejection with a model combining relative fraction and absolute copies of donor-derived cell-free DNA-Results from 5 independent cohorts.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: February 04, 2026

Believing in the Nobel Prize: Long-term Success After HLA-Identical Kidney Transplantation in 3 Monozygotic Twins Without any Induction or Maintenance Immunosuppression.

Journal: Transplantation direct

Published: January 24, 2026

A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation.

Journal: Kidney international

Published: January 23, 2026

High Concordance between ddPCR- and NGS-Based Quantification of Donor-Derived Cell-Free DNA Percentage after Kidney Transplantation.

Journal: Clinical chemistry

Published: December 27, 2025

World Transplant Congress 2025 Highlights: Immunosuppression.

Journal: Transplantation

Published: December 23, 2025

Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: December 19, 2025

Association of Blood Donor-derived Cell-free DNA Levels With Banff Scores and Histopathological Lesions in Kidney Allograft Biopsies: Results From an Observational Study.

Journal: Transplantation direct

Published: January 16, 2025

Estimating the efficacy of felzartamab to treat antibody-mediated rejection using the iBox prognostication system.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: October 07, 2024

Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients.

Journal: Kidney international

Published: July 01, 2024